HBD-3 functionalized Fe/GMP nanozyme combined antimicrobial peptide activity with enzyme-mimicking antioxidant and wound healing functions for multifunctional infection management.
Triple-action materialOne material does three things: kills bacteria (peptide), neutralizes oxidative damage (nanozyme), and promotes healing — addressing all infected wound challenges
What the researchers found
HBD-3-functionalized Fe/GMP nanozyme: triple function — AMP direct killing + SOD/peroxidase mimicking antioxidant + wound healing promotion for comprehensive infection management.
Why it matters
Infected wounds face three challenges: bacteria, oxidative damage, and impaired healing. A single material addressing all three simplifies treatment.
How the study worked
Fe/GMP nanozyme synthesis with HBD-3 functionalization, antimicrobial testing, enzyme-mimicking activity (SOD, peroxidase), ROS scavenging, and wound healing assessment.
What this study cannot tell us
In vitro characterization. In vivo wound healing not fully detailed.
How to read the evidence
In vitro characterization of multifunctional material.
When this study was published
Published in 2025.
The bigger picture
Combining natural AMPs with artificial enzymes creates hybrid biomaterials with capabilities beyond either component alone.
Questions still open
- Could this material be incorporated into wound dressings?
- How long does the triple function persist?
- Would it work against biofilm infections?
Common questions
How does one material do three things?
Could this become a wound dressing?
Read the original research
Human beta-defensin 3-functionalized Fe/GMP nanozyme for multifunctional antimicrobial and anticancer activity against Helicobacter pylori-associated gastrointestinal cancer.
Journal of biotechnology, 410, 67-83
Citation
Kamaraj, Yoganathan; Kumaresan, Veenayohini; Hu, Jinhao; Zhu, Daochen. (2026). Human beta-defensin 3-functionalized Fe/GMP nanozyme for multifunctional antimicrobial and anticancer activity against Helicobacter pylori-associated gastrointestinal cancer.. Journal of biotechnology, 410, 67-83. https://doi.org/10.1016/j.jbiotec.2025.11.018